ACHC
Acadia Healthcare Company, Inc. NASDAQ Listed Mar 4, 1994$24.87
+5.83%
vs $23.50
Mkt Cap $2.3B
52w Low $11.43
71.6% of range
52w High $30.20
50d MA $25.64
200d MA $20.90
P/E (TTM)
-2.0x
EV/EBITDA
—
P/B
1.1x
Debt/Equity
1.4x
ROE
-56.6%
P/FCF
-5.1x
RSI (14)
57.70
ATR (14)
$1.19
Beta
0.71
50d MA
$25.64
200d MA
$20.90
Avg Volume
2.4M
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
6100 Tower Circle · Franklin, TN 37067 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | 0.28 | 0.37 | +32.1% | 28.26 | -4.0% | -8.4% | +7.5% | -0.6% | -8.7% | +0.1% | — |
| Feb 25, 2026 | AMC | 0.03 | 0.07 | +133.3% | 20.84 | +1.8% | +7.0% | +5.2% | +0.0% | -1.9% | +4.7% | — |
| Nov 5, 2025 | AMC | 0.68 | 0.72 | +5.9% | 20.68 | -8.1% | -2.0% | -3.7% | -6.9% | +0.4% | -4.6% | — |
| Aug 5, 2025 | AMC | 0.71 | 0.83 | +16.9% | 21.76 | -4.5% | -17.3% | +1.1% | +5.7% | -0.9% | +6.6% | — |
| May 12, 2025 | AMC | 0.35 | 0.40 | +14.3% | 25.84 | +1.6% | +4.3% | -4.5% | -0.3% | +2.0% | -4.1% | — |
| Feb 27, 2025 | AMC | 0.75 | 0.64 | -14.7% | 40.26 | -19.3% | -25.5% | -2.4% | +4.1% | -2.6% | +0.8% | — |
| Oct 30, 2024 | AMC | 0.90 | 0.91 | +1.1% | 52.08 | -12.6% | -18.0% | -1.6% | +0.7% | +0.4% | -0.0% | — |
| Jul 31, 2024 | AMC | 0.87 | 0.91 | +4.6% | 64.85 | +6.8% | +14.2% | -2.3% | -1.9% | -0.1% | -0.3% | — |
| May 1, 2024 | AMC | 0.81 | 0.84 | +3.7% | 72.99 | -3.9% | -8.6% | -0.9% | +2.5% | -0.5% | -2.0% | — |
| Feb 27, 2024 | AMC | 0.80 | 0.85 | +6.2% | 87.38 | -0.8% | -4.5% | +0.0% | +0.6% | +1.9% | -1.0% | — |
| Nov 2, 2023 | AMC | 0.88 | 0.91 | +3.4% | 73.24 | +2.6% | -1.4% | +1.8% | +1.1% | -0.8% | -2.0% | — |
| Jul 27, 2023 | AMC | 0.86 | 0.92 | +7.0% | 73.36 | +6.2% | +8.3% | -0.5% | -0.7% | +0.4% | -2.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3 | Jefferies | Upgrade | Hold → Buy | $30 | $24.42 | $25.51 | +4.5% | +5.4% | -2.0% | -2.9% | +3.4% | +0.7% |
| May 4 | Raymond James | Upgrade | Outperform → Strong Buy | $39 | $27.85 | $29.38 | +5.5% | -0.6% | -8.7% | +0.1% | -3.3% | +2.9% |
| May 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $25.90 | $25.79 | -0.4% | +7.5% | -0.6% | -8.7% | +0.1% | -3.3% |
| May 1 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $25.90 | $25.79 | -0.4% | +7.5% | -0.6% | -8.7% | +0.1% | -3.3% |
| Apr 28 | TD Cowen | Maintains | Buy → Buy | — | $28.15 | $28.42 | +1.0% | -2.0% | +2.5% | -8.4% | +7.5% | -0.6% |
| Apr 17 | UBS | Maintains | Buy → Buy | — | $26.89 | $27.00 | +0.4% | +0.4% | +3.1% | -1.4% | +2.1% | -2.4% |
| Mar 3 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.44 | $22.84 | -2.6% | -1.9% | +4.7% | +2.5% | +3.9% | -3.6% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $20.84 | $21.22 | +1.8% | +7.0% | +5.2% | +0.0% | -1.9% | +4.7% |
| Feb 26 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $20.84 | $21.22 | +1.8% | +7.0% | +5.2% | +0.0% | -1.9% | +4.7% |
| Feb 26 | RBC Capital | Maintains | Outperform → Outperform | — | $20.84 | $21.22 | +1.8% | +7.0% | +5.2% | +0.0% | -1.9% | +4.7% |
| Feb 26 | TD Cowen | Maintains | Buy → Buy | — | $20.84 | $21.22 | +1.8% | +7.0% | +5.2% | +0.0% | -1.9% | +4.7% |
| Feb 23 | Guggenheim | Maintains | Buy → Buy | — | $16.79 | $16.65 | -0.8% | +3.5% | -1.2% | +21.4% | +7.0% | +5.2% |
| Jan 22 | Jefferies | Downgrade | Buy → Hold | — | $14.33 | $13.85 | -3.3% | +5.7% | +0.5% | +0.0% | -11.5% | -0.3% |
| Jan 16 | TD Cowen | Maintains | Buy → Buy | — | $11.91 | $11.86 | -0.4% | -1.9% | +21.9% | +0.6% | +5.7% | +0.5% |
| Jan 14 | RBC Capital | Maintains | Outperform → Outperform | — | $12.55 | $12.49 | -0.5% | -6.5% | +1.5% | -1.9% | +21.9% | +0.6% |
| Dec 18 | Mizuho | Maintains | Neutral → Neutral | — | $14.53 | $14.48 | -0.3% | -0.7% | -0.1% | +0.3% | -2.5% | +1.4% |
| Dec 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $14.69 | $14.73 | +0.3% | -0.3% | +5.7% | -9.5% | +0.1% | -1.9% |
| Dec 3 | Deutsche Bank | Maintains | Buy → Buy | — | $16.49 | $12.89 | -21.8% | -10.9% | -0.3% | +5.7% | -9.5% | +0.1% |
| Dec 3 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $16.49 | $12.89 | -21.8% | -10.9% | -0.3% | +5.7% | -9.5% | +0.1% |
| Dec 3 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $16.49 | $12.89 | -21.8% | -10.9% | -0.3% | +5.7% | -9.5% | +0.1% |
| Dec 3 | BofA Securities | Downgrade | Neutral → Underperform | — | $16.49 | $12.89 | -21.8% | -10.9% | -0.3% | +5.7% | -9.5% | +0.1% |
| Dec 3 | RBC Capital | Maintains | Outperform → Outperform | — | $16.49 | $12.89 | -21.8% | -10.9% | -0.3% | +5.7% | -9.5% | +0.1% |
| Dec 3 | UBS | Maintains | Buy → Buy | — | $16.49 | $12.89 | -21.8% | -10.9% | -0.3% | +5.7% | -9.5% | +0.1% |
| Dec 3 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $16.49 | $12.89 | -21.8% | -10.9% | -0.3% | +5.7% | -9.5% | +0.1% |
| Nov 18 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $15.65 | $15.65 | +0.0% | -4.1% | -4.5% | +0.1% | +5.7% | +2.4% |
| Nov 12 | RBC Capital | Maintains | Outperform → Outperform | — | $18.24 | $18.20 | -0.2% | -4.6% | -7.6% | -0.4% | -2.3% | -4.1% |
| Nov 10 | Guggenheim | Maintains | Buy → Buy | — | $19.51 | $19.19 | -1.6% | -6.9% | +0.4% | -4.6% | -7.6% | -0.4% |
| Nov 7 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $20.26 | $19.75 | -2.5% | -3.7% | -6.9% | +0.4% | -4.6% | -7.6% |
| Nov 7 | UBS | Maintains | Buy → Buy | — | $20.26 | $19.75 | -2.5% | -3.7% | -6.9% | +0.4% | -4.6% | -7.6% |
| Nov 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $20.68 | $19.00 | -8.1% | -2.0% | -3.7% | -6.9% | +0.4% | -4.6% |
| Oct 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $27.23 | $26.74 | -1.8% | -6.0% | -1.6% | -3.7% | +0.1% | +2.6% |
| Oct 7 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $26.46 | $26.70 | +0.9% | +2.9% | -6.0% | -1.6% | -3.7% | +0.1% |
| Oct 3 | Raymond James | Maintains | Outperform → Outperform | — | $26.62 | $26.53 | -0.3% | +2.0% | -2.5% | +2.9% | -6.0% | -1.6% |
| Sep 10 | BofA Securities | Downgrade | Buy → Neutral | — | $23.30 | $22.64 | -2.8% | -9.6% | +5.9% | -2.6% | -1.4% | +1.4% |
| Aug 14 | Raymond James | Downgrade | Strong Buy → Outperform | — | $20.77 | $19.92 | -4.1% | -0.5% | +1.5% | +0.7% | +2.2% | -1.3% |
| Aug 14 | Mizuho | Maintains | Neutral → Neutral | — | $20.77 | $19.92 | -4.1% | -0.5% | +1.5% | +0.7% | +2.2% | -1.3% |
| Aug 13 | RBC Capital | Maintains | Outperform → Outperform | — | $20.33 | $20.25 | -0.4% | +2.2% | -0.5% | +1.5% | +0.7% | +2.2% |
| Aug 7 | UBS | Maintains | Buy → Buy | — | $18.00 | $18.17 | +0.9% | +1.1% | +5.7% | -0.9% | +6.6% | +2.2% |
| Aug 7 | Barclays | Maintains | Equal Weight → Equal Weight | — | $18.00 | $18.17 | +0.9% | +1.1% | +5.7% | -0.9% | +6.6% | +2.2% |
| Aug 7 | TD Cowen | Maintains | Buy → Buy | — | $18.00 | $18.17 | +0.9% | +1.1% | +5.7% | -0.9% | +6.6% | +2.2% |
| Aug 7 | Guggenheim | Maintains | Buy → Buy | — | $18.00 | $18.17 | +0.9% | +1.1% | +5.7% | -0.9% | +6.6% | +2.2% |
| May 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $26.94 | $27.00 | +0.2% | -4.5% | -0.3% | +2.0% | -4.1% | +0.5% |
| May 14 | Mizuho | Maintains | Neutral → Neutral | — | $26.94 | $27.00 | +0.2% | -4.5% | -0.3% | +2.0% | -4.1% | +0.5% |
| May 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $26.94 | $27.00 | +0.2% | -4.5% | -0.3% | +2.0% | -4.1% | +0.5% |
| May 13 | BofA Securities | Maintains | Buy → Buy | — | $25.84 | $26.26 | +1.6% | +4.3% | -4.5% | -0.3% | +2.0% | -4.1% |
| Apr 3 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $29.21 | $28.70 | -1.7% | -2.8% | -3.6% | -3.5% | +2.6% | +7.3% |
| Mar 25 | Mizuho | Maintains | Neutral → Neutral | — | $28.94 | $29.06 | +0.4% | -0.4% | +3.0% | +1.6% | +0.0% | +0.7% |
| Mar 3 | RBC Capital | Maintains | Outperform → Outperform | — | $29.98 | $30.46 | +1.6% | -2.4% | +4.1% | -2.6% | +0.8% | +2.2% |
| Mar 3 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $29.98 | $30.46 | +1.6% | -2.4% | +4.1% | -2.6% | +0.8% | +2.2% |
| Feb 28 | Barclays | Downgrade | Overweight → Equal Weight | — | $40.26 | $32.50 | -19.3% | -25.5% | -2.4% | +4.1% | -2.6% | +0.8% |
No insider trades available.
8-K
Acadia Healthcare Company, Inc. -- 8-K Filing
May 18
8-K · 7.01
! Medium
Acadia Healthcare Company, Inc. -- 8-K 7.01: Regulation FD Disclosure
Acadia Healthcare announced a Chief Financial Officer transition on April 23, 2026, signaling potential strategic shifts in financial management and company direction.
Apr 23
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Without seeing the actual press release content, I cannot provide specific analysis; however, investors should review Exhibit 99.1 immediately to assess whether disclosed matters affect earnings guidance, operations, or competitive positioning.
Mar 12
8-K · 7.01
! Medium
Acadia Healthcare Company, Inc. -- 8-K 7.01: Regulation FD Disclosure
Acadia Healthcare will host a February 25, 2026 earnings call to discuss fourth-quarter 2025 results, with presentation slides available for investor reference.
Feb 25
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 6,867,678 | $161M | Added | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 5,061,438 | $118M | New | Mar 2026 |
| 3 | Deerfield Management Company, L.p. | 4,520,000 | $106M | — | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 4,154,801 | $97M | New | Mar 2026 |
| 5 | Ubs Group Ag | 2,833,862 | $66M | Added | Mar 2026 |
| 6 | Citadel Advisors Llc | 2,716,425 | $64M | Added | Mar 2026 |
| 7 | Neuberger Berman Group Llc | 1,961,384 | $46M | Added | Mar 2026 |
| 8 | Morgan Stanley | 3,056,952 | $43M | Reduced | Dec 2025 |
| 9 | Farallon Capital Management Llc | 1,736,800 | $41M | New | Mar 2026 |
| 10 | First Trust Advisors Lp | 1,689,442 | $40M | Added | Mar 2026 |
| 11 | Citigroup Inc | 2,574,940 | $37M | Added | Dec 2025 |
| 12 | Maverick Capital Ltd | 1,314,116 | $31M | Added | Mar 2026 |
| 13 | Bank Of America Corp /de/ | 1,231,172 | $29M | Added | Mar 2026 |
| 14 | Man Group Plc | 794,474 | $19M | New | Mar 2026 |
| 15 | Susquehanna International Group, Llp | 742,902 | $17M | Added | Mar 2026 |
| 16 | Northern Trust Corp | 728,941 | $17M | Added | Mar 2026 |
| 17 | Cibc Bancorp Usa Inc. | 690,530 | $16M | New | Mar 2026 |
| 18 | Invesco Ltd. | 583,166 | $14M | Reduced | Mar 2026 |
| 19 | Point72 Asset Management | 536,517 | $13M | New | Mar 2026 |
| 20 | Amundi | 525,084 | $12M | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.29B
Enterprise Value
$4.59B
P/E (TTM)
-2.05x
Forward P/E
16.88x
PEG Ratio
0.00x
P/B
1.05x
P/S
0.68x
P/FCF
-5.13x
EV/EBITDA
—
Shares Out
90.7M
Financials (TTM)
Revenue
$3.31B
Net Income
-$1.10B
EBITDA
-$737.8M
Free Cash Flow
-$439.9M
Op Cash Flow
$131.9M
EPS Basic
$-12.16
EPS Diluted
$-12.16
EPS Forward
$1.47
Gross Margin
17.6%
Op Margin
11.7%
Net Margin
-33.3%
Balance Sheet
Total Assets
$5.53B
Total Liab.
$3.39B
Total Equity
$2.14B
Cash
$133.2M
LT Debt
$2.47B
Book Value/Sh
$23.60
Debt/Equity
1.36x
Current Ratio
1.55
Quick Ratio
1.54
Returns & Growth
ROE
-56.6%
ROA
-20.0%
ROIC
7.7%
Rev Growth YoY
+5.0%
EPS Growth YoY
-535.8%
Price Returns
2W
-13.4%
1M
-10.4%
3M
-1.0%
6M
+34.9%
12M
+2.5%
Technicals
52W High
$30.20
52W Low
$11.43
50d MA
$25.64
200d MA
$20.90
RSI (14)
57.70
ATR (14)
$1.19
Beta
0.71
Avg Volume
2.4M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$22.32
High
$31.00
Low
$17.00
Median
$22.00
Data updated apr 24, 2026 10:31am
· Source: financialmodelingprep.com